Q1 2026 Holdings
Filed 2026-05-14 | 17 holdings | $364.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pfizer Inc(PFE) | COM | 717081103 | $44.8M | 1,593,942 | 12.3% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $34.6M | 44,800 | 9.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $29.9M | 182,562 | 8.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $29.1M | 386,903 | 8.0% |
| Natera Inc(NTRA) | COM | 632307104 | $28.8M | 143,966 | 7.9% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $27.1M | 305,055 | 7.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $25.6M | 35,045 | 7.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $25.1M | 27,279 | 6.9% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $24.9M | 520,009 | 6.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $24.2M | 873,398 | 6.6% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $23.8M | 1,314,748 | 6.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $12.1M | 447,153 | 3.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $8.7M | 78,125 | 2.4% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $7.4M | 591,800 | 2.0% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $6.5M | 261,200 | 1.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $6.1M | 126,461 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.9M | 302,457 | 1.6% |